Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lawren Wu is active.

Publication


Featured researches published by Lawren Wu.


Bioanalysis | 2016

Fit-for-purpose biomarker immunoassay qualification and validation: three case studies

Kyra J. Cowan; Xiaoying Gao; Vaishali Parab; Trung Nguy; Lawren Wu; Joseph R. Arron; Michael J. Townsend; Jeffrey Wallin; Melissa Cheu; Alyssa Morimoto; Eric Wakshull

AIM To improve on the efficiency of biomarker assay readiness, and for reliable biomarker data to support three drug programs, we implemented a fit-for-purpose approach, qualifying two biomarker assays and validating a third. Results/methodology: The qualification strategy and selection of experiments for two exploratory biomarkers (CXCL1, CCL19) was determined by the intended use of the biomarker data. The third biomarker, IL-6, was validated as the data would be used in monitoring patient safety during dose-escalation studies in a Phase I trial. All three assays passed a priori acceptance criteria. CONCLUSION These assays highlight strategies and methodologies for a fit-for-purpose approach. Minimum qualification, full qualification and validation were chosen and supported programs at different stages of drug development.


Archive | 2008

Apoptotic anti-IgE antibodies

Lawren Wu; Mercedesz Balazs; Hans Brightbill; Andrew T. Chan; Yvonne Chen; Anan Chuntharapai; Mark S. Dennis; Terence Wong


Archive | 2011

Nucleic acid encoding apoptotic anti-IgE antibodies

Lawren Wu; Mercedesz Balazs; Hans Brightbill; Andrew T. Chan; Yvonne Chen; Anan Chuntharapai; Mark S. Dennis; Terence Wong


Archive | 2011

Methods of using apoptotic anti-IGE antibodies

Lawren Wu; Mercedesz Balazs; Hans Brightbill; Andrew T. Chan; Yvonne Chen; Anan Chuntharapai; Mark S. Dennis; Terence Wong


Archive | 2015

ANTI-IL-13/IL-17 BISPECIFIC ANTIBODIES AND USES THEREOF

Lawren Wu; Joseph R. Arron; Michael Dillon; David F. Choy; Sue Sohn; Christoph Spiess; Whitney Shatz


Archive | 2008

Apoptotic anti- IgE antibodies binding the membrane-bound IgE

Lawren Wu; Mercedesz Balazs; Hans Brightbill; Andrew T. Chan; Yvonne Chen; Anan Chuntharapai; Mark S. Dennis; Terence Wong


Archive | 2011

Transgenic animals expressing human ige-m1'

Lawren Wu; Mercedesz Balazs; Hans Brightbill; Andrew T. Chan; Yvonne Chen; Anan Chuntharapai; Mark S. Dennis; Terence Wong


Cancer Research | 2018

Abstract 2559: Generation and evaluation of an FLT3 CAR-T cell therapy for the treatment of acute myeloid leukemia

Alice Bakker; Hervé Lebrec; Bettina Lindl; Gregor B. Adams; Armen Mardiros; Priya Koppikar; Chi Ming Li; Mei Gong; Yan Zheng; Christine Sastri; Mercedesz Balazs; Rebecca L. Goldstein; Dan A. Rock; Lawren Wu; Anthony Polverino; Marion Subklewe; Angela Coxon; Tara Arvedson


Archive | 2015

Anticorps bispécifiques anti-il-13/il-17 et leurs utilisations

Lawren Wu; Joseph R. Arron; Michael Patrick Dillon; David F. Choy; Sue Sohn; Christoph Spiess; Whitney Shatz


European Respiratory Journal | 2015

CEACAM6-high airway neutrophils and epithelial cells are a feature of severe asthma

Aarti Shikotra; David F. Choy; Salman Siddiqui; Greer Arthur; Deepti R. Nagarkar; Jia Guiquan; Chandra M. Ohri; Emma Doran; Claire A. Butler; Beverley Hargadon; Alexander R. Abbas; Janet Jackman; Lawren Wu; Liam Heaney; Joe Arron; Peter Bradding

Collaboration


Dive into the Lawren Wu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge